CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-464

I definitely think they are watching closely for the results later this month, especially after this recent reimbursement news this would definitely be a major target. Lesser devices were being acquired for close to a billion dollars in 2022

$1 seems pretty appealing now whilst this is trading at 22c, but I'm guessing if an offer is made and the price quickly shoots to that price, investors will become much more difficult to budge. I suspect we will look at the fundamentals, and realise that even at $1 an acquirer is getting a bargain price for this (given the size of the growth runway here)